BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 3542373)

  • 1. Partial correction of lipid disturbances by insulin in experimental renal failure.
    Roullet JB; Lacour B; Drueke T
    Contrib Nephrol; 1986; 50():203-10. PubMed ID: 3542373
    [No Abstract]   [Full Text] [Related]  

  • 2. Correction by insulin of disturbed TG-rich LP metabolism in rats with chronic renal failure.
    Roullet JB; Lacour B; Yvert JP; Drueke T
    Am J Physiol; 1986 Apr; 250(4 Pt 1):E373-6. PubMed ID: 3515962
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypertriglyceridemia and lipoprotein lipase activity in experimental uremia.
    Kraemer FB; Chen YD; Reaven GM
    Nephron; 1982; 30(3):274-8. PubMed ID: 7099342
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Obesity: changes in lipid metabolism and the role of insulin.
    Nestel P; Goldrick B
    Clin Endocrinol Metab; 1976 Jul; 5(2):313-35. PubMed ID: 182418
    [No Abstract]   [Full Text] [Related]  

  • 5. Restoration of lipoprotein lipase activity in insulin-deficient rats by insulin infusion is tissue-specific.
    Deshaies Y; Géloën A; Paulin A; Bukowiecki LJ
    Can J Physiol Pharmacol; 1991 Jun; 69(6):746-51. PubMed ID: 1913321
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The regulation of adipose cell metabolism.
    Galton DJ; Wallis S
    Proc Nutr Soc; 1982 Jun; 41(2):167-73. PubMed ID: 7051014
    [No Abstract]   [Full Text] [Related]  

  • 7. Effects of intravenous nutrition on lipoprotein metabolism, body composition, weight gain and uremic state in experimental uremia in rats.
    Wennberg A; Norbeck HE; Sterner G; Lundholm K
    J Nutr; 1991 Sep; 121(9):1439-46. PubMed ID: 1908894
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lipoprotein and carbohydrate disorders in nephrotic syndrome and uremia.
    Kleinknecht D; Laudat MH; Strauch G; Jungers P; Laudat P
    Rev Eur Etud Clin Biol; 1972 Jan; 17(1):27-37. PubMed ID: 5041347
    [No Abstract]   [Full Text] [Related]  

  • 9. Protective effect of rutin on lipids, lipoproteins, lipid metabolizing enzymes and glycoproteins in streptozotocin-induced diabetic rats.
    Stanely Mainzen Prince P; Kannan NK
    J Pharm Pharmacol; 2006 Oct; 58(10):1373-83. PubMed ID: 17034661
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of portal and peripheral insulin delivery on lipid metabolism in streptozocin-diabetic rats.
    Kruszynska YT; Home PD; Alberti KG
    Diabetes; 1985 Jun; 34(6):611-6. PubMed ID: 3891472
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disorders of blood-lipids in renal disease.
    Cramp DG; Moorhead JF; Wills MR
    Lancet; 1975 Mar; 1(7908):672-3. PubMed ID: 47091
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Abnormalities of carbohydrate and lipid metabolism in uremia.
    Bierman EL
    Arch Intern Med; 1970 Nov; 126(5):790-2. PubMed ID: 5475702
    [No Abstract]   [Full Text] [Related]  

  • 13. Parathyroid hormone and triglyceride transport: effects on triglyceride secretion rates and adipose tissue lipoprotein lipase in the rat.
    Bagdade J; Yee E; Pykalisto OJ
    Horm Metab Res; 1978 Sep; 10(5):443-6. PubMed ID: 213359
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanism(s) of hyperlipidemia in chronic uremia.
    Bagdade JD; Shafrir E; Wilson DE
    Trans Am Soc Artif Intern Organs; 1976; 22():42-5. PubMed ID: 181888
    [No Abstract]   [Full Text] [Related]  

  • 15. [Hyperlipidemia in rats with chronic renal failure].
    Nikiforova NV; Tananaeva IK; Pozdniakov AL; Sokolovskaia IV
    Biull Eksp Biol Med; 1978 Jun; 85(6):676-9. PubMed ID: 208685
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Response of adipose tissue lipoprotein lipase activity and serum lipoproteins to acute hyperinsulinaemia in man.
    Yki-Järvinen H; Taskinen MR; Koivisto VA; Nikkilä EA
    Diabetologia; 1984 Sep; 27(3):364-9. PubMed ID: 6389242
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Very low density lipoprotein metabolism after insulin over-treatment and during a euglycaemic clamp.
    Kruszynska YT; Home PD; Alberti KG
    Eur J Clin Invest; 1987 Feb; 17(1):23-8. PubMed ID: 3106047
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Uremia and the liver. III. Uremia and hepatic metabolism of carbohydrates, lipids, and proteins.
    Brissot P; Simon P; Meyrier A
    Nephron; 1981; 29(1-2):14-17. PubMed ID: 7035979
    [No Abstract]   [Full Text] [Related]  

  • 19. Lipoprotein particle abnormalities and the impaired lipolysis in renal insufficiency.
    Lee DM; Knight-Gibson C; Samuelsson O; Attman PO; Wang CS; Alaupovic P
    Kidney Int; 2002 Jan; 61(1):209-18. PubMed ID: 11786103
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lipid metabolism in uremia and the effects of dialysate glucose and oral androgen therapy.
    Dombeck DH; Lindholm DD; Vieira JA
    Trans Am Soc Artif Intern Organs; 1973; 19():150-3. PubMed ID: 4352987
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.